| Positive Results from Phase 2 Study of Atrasentan for Treatment of Diabetic ... - VAdvert Press Center (press release) |
|
|
VAdvert Press Center (press release) Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology. The published study results suggest that atrasentan, |